Vanguard Group Inc Fulgent Genetics, Inc. Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,424,448 shares of FLGT stock, worth $29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,424,448

Previous 1,416,191 0.58%

Holding current value

$29 Million

Previous $40.9 Million 24.5%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$21.55 - $29.29 $177,938 - $241,847	8,257 Added 0.58%	1,424,448 $30.9 Million
Q4 2023 Feb 14, 2024	BUY	$23.64 - $30.27 $531,427 - $680,469	22,480 Added 1.61%	1,416,191 $40.9 Million
Q3 2023 Nov 14, 2023	BUY	$26.74 - $40.81 $83,936 - $128,102	3,139 Added 0.23%	1,393,711 $37.3 Million
Q2 2023 Aug 14, 2023	BUY	$28.52 - $40.7 $351,394 - $501,464	12,321 Added 0.89%	1,390,572 $51.5 Million
Q1 2023 May 15, 2023	SELL	$29.39 - $36.27 $457,984 - $565,195	-15,583 Reduced 1.12%	1,378,251 $43 Million

Q4 2022 Feb 10, 2023	BUY	$29.23 - $40.28 $821,304 - $1.13 Million	28,098 Added 2.06%	1,393,834 $41.5 Million
Q3 2022 Nov 14, 2022	BUY	$37.92 - $63.74 $1.22 Million - $2.05 Million	32,173 Added 2.41%	1,365,736 $52.1 Million
Q2 2022 Aug 12, 2022	SELL	$47.98 - $62.75 $278,667 - $364,452	-5,808 Reduced 0.43%	1,333,563 $72.7 Million
Q1 2022 May 13, 2022	BUY	$49.85 - $96.11 $1.33 Million - $2.57 Million	26,731 Added 2.04%	1,339,371 $83.6 Million
Q4 2021 Feb 14, 2022	BUY	$77.3 - $105.0 $379,233 - $515,130	4,906 Added 0.38%	1,312,640 $132 Million
Q3 2021 Nov 12, 2021	BUY	$74.87 - $110.87 $2.11 Million - $3.12 Million	28,175 Added 2.2%	1,307,734 $118 Million
Q2 2021 Aug 13, 2021	BUY	$66.8 - $100.45 $85.5 Million - $129 Million	1,279,559 New	1,279,559 $118 Million

Others Institutions Holding FLGT

# of Institutions

199

Shares Held

14.7M

Call Options Held

1.16M

Put Options Held

92.9K

View Full List

About Fulgent Genetics, Inc.

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $617M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

More about FLGT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Fulgent Genetics, Inc. Transaction History